 |
PDBsum entry 4z7h
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.1.26.-
- ?????
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Oncotarget
6:13019-13035
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular mechanisms of human IRE1 activation through dimerization and ligand binding.
|
|
A.Joshi,
Y.Newbatt,
P.C.McAndrew,
M.Stubbs,
R.Burke,
M.W.Richards,
C.Bhatia,
J.J.Caldwell,
T.McHardy,
I.Collins,
R.Bayliss.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
IRE1 transduces the unfolded protein response by splicing XBP1 through its
C-terminal cytoplasmic kinase-RNase region. IRE1 autophosphorylation is coupled
to RNase activity through formation of a back-to-back dimer, although the
conservation of the underlying molecular mechanism is not clear from existing
structures. We have crystallized human IRE1 in a back-to-back conformation only
previously seen for the yeast homologue. In our structure the kinase domain
appears primed for catalysis but the RNase domains are disengaged.
Structure-function analysis reveals that IRE1 is autoinhibited through a
Tyr-down mechanism related to that found in the unrelated Ser/Thr protein kinase
Nek7. We have developed a compound that potently inhibits human IRE1 kinase
activity while stimulating XBP1 splicing. A crystal structure of the inhibitor
bound to IRE1 shows an increased ordering of the kinase activation loop. The
structures of hIRE in apo and ligand-bound forms are consistent with a
previously proposed model of IRE1 regulation in which formation of a
back-to-back dimer coupled to adoption of a kinase-active conformation drive
RNase activation. The structures provide opportunities for structure-guided
design of IRE1 inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |